Search results for Lutikizumab
Lutikizumab Biosimilar – Anti-IL1A , IL1B mAb – Research Grade, ProteoGenix, PX-TA1440
Description of Lutikizumab Biosimilar - Anti-IL1A , IL1B mAb - Research Grade General information on Anti-IL1A /IL1B[Homo sapiens] (Lutikizumab) Monoclonal Antibody Lutikizumab is investigated for the treatment of Knee Osteoarthritis.
Host
Reactivity
Applications
Conjugation
Lutikizumab, Abbexa, abx831397
Lutikizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL1A/IL1B, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Research Grade Lutikizumab (HF802026), abinScience, HF802026
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.